REQUEST A DEMO
Total
USD $0.00
Search more companies

Diamond Drugs Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Diamond Drugs Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Diamond Drugs Private Limited is an unlisted company, incorporated on 15/12/2004. It has its registered office in the State of West Bengal, India. Company's corporate identification number (CIN) is U24239WB2004PTC100709 and registration number is 100709. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
37 Sri Gopal Mullick Lane
Kolkata; West Bengal; Postal Code: 700037

Contact Details: Purchase the Diamond Drugs Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Diamond Drugs Private Limited report to view the information.
Outstanding Shares:
Purchase the Diamond Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Diamond Drugs Private Limited report to view the information.
Incorporation Date:
December 15, 2004
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Diamond Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
0.86%
Total operating revenue
1.9%
Operating profit (EBIT)
77.21%
EBITDA
71.62%
Net Profit (Loss) for the Period
79.69%
Total assets
16.75%
Total equity
31.28%
Operating Profit Margin (ROS)
8.87%
Net Profit Margin
6.85%
Return on Equity (ROE)
6.42%
Debt to Equity Ratio
-2%
Quick Ratio
2.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?